Evaxion Biotech AS (EVAX)
1.42
+0.05
(+3.65%)
USD |
NASDAQ |
Nov 22, 16:00
1.42
0.00 (0.00%)
After-Hours: 20:00
Evaxion Biotech Shareholders Equity (Quarterly): 0.074M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 0.074M |
| June 30, 2024 | 1.253M |
| March 31, 2024 | 5.533M |
| December 31, 2023 | -4.739M |
| September 30, 2023 | -89.76M |
| June 30, 2023 | 2.535M |
| March 31, 2023 | -78.72M |
| December 31, 2022 | 8.303M |
| September 30, 2022 | -65.76M |
| Date | Value |
|---|---|
| June 30, 2022 | 20.15M |
| March 31, 2022 | 26.39M |
| December 31, 2021 | 32.44M |
| September 30, 2021 | 16.65M |
| June 30, 2021 | 21.83M |
| March 31, 2021 | 27.80M |
| December 31, 2020 | 7.038M |
| September 30, 2020 | 7.903M |
| December 31, 2019 | 9.362M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-89.76M
Minimum
Sep 2023
32.44M
Maximum
Dec 2021
-2.874M
Average
7.470M
Median
Shareholders Equity (Quarterly) Benchmarks
| Ascendis Pharma AS | -108.70M |
| DBV Technologies SA | 54.03M |
| Adaptimmune Therapeutics PLC | 79.99M |
| Akari Therapeutics PLC | -6.694M |
| Biodexa Pharmaceuticals PLC | 11.04M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 15.18M |
| Total Liabilities (Quarterly) | 15.18M |
| Net Debt Paydown Yield | 7.96% |